A transcriptional metabolic gene-set based prognostic signature is associated with clinical and mutational features in head and neck squamous cell carcinoma
Conclusion6MPS functions not only as a promising predictor of prognosis and survival but also as potential marker for therapeutic schedule monitoring.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Head and Neck Cancer | HNSCC | Skin Cancer | Squamous Cell Carcinoma | Training | Universities & Medical Training